Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $287.70 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ardelyx, Inc. | $123.03 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $90.68 | 2 | $0 (2024) |
| PFIZER INC. | $30.15 | 2 | $0 (2024) |
| Genentech USA, Inc. | $28.50 | 5 | $0 (2021) |
| Lilly USA, LLC | $15.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $227.21 | 4 | Ardelyx, Inc. ($123.03) |
| 2023 | $16.65 | 1 | PFIZER INC. ($16.65) |
| 2021 | $43.84 | 6 | Genentech USA, Inc. ($28.50) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $123.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 05/01/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $76.11 | General |
| Category: Respiratory | ||||||
| 07/07/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/27/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Virology & Specialty Care | ||||||
| 04/23/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Neuroscience | ||||||
| 02/16/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: Virology & Specialty Care | ||||||
| 02/09/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: Virology & Specialty Care | ||||||
| 02/02/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: Virology & Specialty Care | ||||||
| 01/22/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 236 | 319 | $35,067 | $11,693 |
| 2022 | 9 | 177 | 180 | $31,197 | $10,265 |
| 2021 | 6 | 172 | 176 | $32,275 | $12,400 |
| 2020 | 5 | 313 | 323 | $57,054 | $21,721 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 47 | $9,729 | $3,882 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 36 | 39 | $5,265 | $1,943 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $5,328 | $1,863 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,796 | $1,336 | 27.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 34 | 38 | $3,800 | $1,316 | 34.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 26 | 54 | $2,754 | $875.88 | 31.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 14 | $686.00 | $226.80 | 33.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 22 | $1,122 | $188.58 | 16.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 21 | $483.00 | $46.20 | 9.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 11 | 46 | $1,104 | $15.21 | 1.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 22 | 23 | $4,761 | $2,033 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 30 | $4,050 | $1,751 | 43.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,662 | $1,627 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $5,014 | $1,425 | 28.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 33 | 33 | $3,300 | $1,399 | 42.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,135 | $1,336 | 42.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 15 | 15 | $5,250 | $457.59 | 8.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 12 | 12 | $588.00 | $194.56 | 33.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 19 | $437.00 | $41.92 | 9.6% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 56 | 57 | $5,700 | $2,578 | 45.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $6,976 | $2,440 | 35.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,327 | $2,415 | 38.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 21 | $4,347 | $2,071 | 47.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 35 | $4,725 | $2,014 | 42.6% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 12 | 12 | $4,200 | $881.88 | 21.0% |
About Ryne Least, PA-C
Ryne Least, PA-C is a Community Health Worker healthcare provider based in Tallahassee, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2015. The National Provider Identifier (NPI) number assigned to this provider is 1659751709.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryne Least, PA-C has received a total of $287.70 in payments from pharmaceutical and medical device companies, with $227.21 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($287.70).
As a Medicare-enrolled provider, Least has provided services to 898 Medicare beneficiaries, totaling 998 services with total Medicare billing of $56,079. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Community Health Worker
- Other Specialties Medical
- Location Tallahassee, FL
- Active Since 06/04/2015
- Last Updated 02/26/2019
- Taxonomy Code 172V00000X
- Entity Type Individual
- NPI Number 1659751709
Products in Payments
- IBSRELA (Drug) $123.03
- AIRSUPRA (Drug) $90.68
- PAXLOVID (Drug) $30.15
- Xofluza (Drug) $28.50
- EMGALITY (Drug) $15.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Community Health Worker Doctors in Tallahassee
Helen Webb
Community Health Worker
Mr. Gari Tookes, Lcsw, Mcap, Ic&Rc, LCSW, MCAP, IC&RC
Community Health Worker
Miss. Yaquanda Byrd
Community Health Worker
Lavern Pettaway, Arnp, ARNP
Community Health Worker
Mrs. Teresa Whitehead-Carter
Community Health Worker
Lurlene Williams
Community Health Worker